BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 26633638)

  • 1. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
    Haberer JE
    Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Welcome to the preexposure prophylaxis revolution.
    Baeten J; McCormack S
    Curr Opin HIV AIDS; 2016 Jan; 11(1):1-2. PubMed ID: 26633637
    [No Abstract]   [Full Text] [Related]  

  • 3. The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA.
    Elion R; Coleman M
    Curr Opin HIV AIDS; 2016 Jan; 11(1):67-73. PubMed ID: 26599165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.
    Mugo NR; Ngure K; Kiragu M; Irungu E; Kilonzo N
    Curr Opin HIV AIDS; 2016 Jan; 11(1):80-6. PubMed ID: 26575147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European preexposure prophylaxis revolution.
    Cairns G; McCormack S; Molina JM
    Curr Opin HIV AIDS; 2016 Jan; 11(1):74-9. PubMed ID: 26599164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.
    Thomson KA; Baeten JM; Mugo NR; Bekker LG; Celum CL; Heffron R
    Curr Opin HIV AIDS; 2016 Jan; 11(1):18-26. PubMed ID: 26417954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?
    Parikh UM; Mellors JW
    Curr Opin HIV AIDS; 2016 Jan; 11(1):49-55. PubMed ID: 26633640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nondaily preexposure prophylaxis for HIV prevention.
    Anderson PL; García-Lerma JG; Heneine W
    Curr Opin HIV AIDS; 2016 Jan; 11(1):94-101. PubMed ID: 26633641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promise and pitfalls of pre-exposure prophylaxis for female sex workers.
    Cowan FM; Delany-Moretlwe S
    Curr Opin HIV AIDS; 2016 Jan; 11(1):27-34. PubMed ID: 26633639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.
    Koss CA; Hosek SG; Bacchetti P; Anderson PL; Liu AY; Horng H; Benet LZ; Kuncze K; Louie A; Saberi P; Wilson CM; Gandhi M
    Clin Infect Dis; 2018 Jan; 66(2):213-219. PubMed ID: 29020194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
    Krakower DS; Mayer KH
    Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical issues in trials of preexposure prophylaxis.
    Dunn DT; Glidden DV
    Curr Opin HIV AIDS; 2016 Jan; 11(1):116-21. PubMed ID: 26545264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    Wang X; Nwokolo N; Korologou-Linden R; Hill A; Whitlock G; Day-Weber I; McClure MO; Boffito M
    HIV Med; 2018 Jan; 19(1):1-6. PubMed ID: 28657199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preexposure Prophylaxis (PrEP) for HIV Prevention: The Primary Care Perspective.
    Conniff J; Evensen A
    J Am Board Fam Med; 2016; 29(1):143-51. PubMed ID: 26769887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination.
    Thaden JT; Gandhi M; Okochi H; Hurt CB; McKellar MS
    AIDS; 2018 Jun; 32(9):F1-F4. PubMed ID: 29683856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of healthcare providers in the roll out of preexposure prophylaxis.
    Krakower DS; Mayer KH
    Curr Opin HIV AIDS; 2016 Jan; 11(1):41-8. PubMed ID: 26417953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa.
    Musinguzi N; Muganzi CD; Boum Y; Ronald A; Marzinke MA; Hendrix CW; Celum C; Baeten JM; Bangsberg DR; Haberer JE;
    AIDS; 2016 Apr; 30(7):1121-9. PubMed ID: 26785125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa.
    Matthews LT; Jaggernath M; Kriel Y; Smith PM; Haberer JE; Baeten JM; Hendrix CW; Ware NC; Moodley P; Pillay M; Bennett K; Bassler J; Psaros C; Hurwitz KE; Bangsberg DR; Smit JA
    AIDS; 2024 Jul; 38(9):1342-1354. PubMed ID: 38752557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness.
    Amico KR
    Curr Opin HIV AIDS; 2012 Nov; 7(6):542-8. PubMed ID: 22964887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What people want from sex and preexposure prophylaxis.
    Grant RM; Koester KA
    Curr Opin HIV AIDS; 2016 Jan; 11(1):3-9. PubMed ID: 26569183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.